文献速递男科与性医学

不育男性Y染色体微缺失频率及基因检测精子浓度阈值分析

An analysis of the frequency of Y-chromosome microdeletions and the determination of a threshold sperm concentration for genetic testing in infertile men.
PubMed 文献 · BJU Int · 2018-09-09

英国伦敦多种族城市人群回顾性队列研究,纳入1473例男性不育症患者,Y染色体微缺失患病率为4%(n=58)。高FSH水平(P<0.001)和低精子浓度(P<0.05)为微缺失的显著预测因素。将精子浓度阈值降至0.5百万/mL可保持100%敏感性并提高特异性至31%,与现行指南相比可显著节省成本。

要点

  • 不育男性Y染色体微缺失患病率为4%(n=58)。
  • 高FSH(P<0.001)和低精子浓度(P<0.05)为微缺失显著预测因素。
  • 精子浓度阈值0.5百万/mL保持100%敏感性,特异性提高至31%。

核心结论

  • 不育男性Y染色体微缺失患病率在不同人群和国家间存在差异。
  • 低精子浓度是识别微缺失的预测因素(P<0.05)。
  • 基因检测阈值设为0.5百万/mL可提高特异性并降低相对成本,而不影响敏感性。

研究设计与样本

  • 所有患者均接受遗传学评估、激素谱检测和2次异常精液分析。
  • 检查异常者另行针对性影像学检查。

主要发现

  • 微缺失患病率为4%(n=58)。
  • 微缺失分区:AZFc 75%,AZFb+c 13.8%,AZFb 6.9%,AZFa 1.7%,部分AZFa 1.7%。
  • 高FSH水平(P<0.001)和低精子浓度(P<0.05)均为微缺失的显著预测因素。
  • 睾酮水平、LH水平和睾丸体积未预测微缺失的存在。
  • 无AZF微缺失患者精子浓度>0.5百万/mL。

关键数值与推荐

  • 精子浓度阈值降至0.5百万/mL,保持敏感性100%,特异性提高至31%。
  • 与欧洲男科学会/欧洲分子遗传学质量网络和欧洲泌尿外科学会指南相比,该阈值可显著节省成本。

临床怎么用

  • 对不育男性,尤其高FSH和低精子浓度者,应进行Y染色体微缺失基因检测。
  • 可考虑将基因检测精子浓度阈值设为0.5百万/mL,以优化特异性和成本效益。

局限性

  • 单中心回顾性研究,结果可能受转诊人群特征影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the prevalence of Y-chromosome microdeletions in a multi-ethnic urban population in London, UK. To also determine predictive factors and a clinical threshold for genetic testing in men with Y chromosome microdeletions. PATIENTS AND METHODS: A retrospective cohort study of 1473 men that were referred to a tertiary Andrology centre with male factor infertility between July 2004 and December 2016. All had a genetic evaluation, hormonal profile and 2 abnormal semen analyses. Those with abnormal examination findings also had targeted imaging performed. RESULTS: The prevalence of microdeletions was 4% (n = 58) in this study. These microdeletions were partitioned into the following regions: Azoospermia factors (AZF); AZFc (75%), AZFb+c (13.8%), AZFb (6.9%), AZFa (1.7%), and partial AZFa (1.7%). A high follicle-stimulating hormone level (P < 0.001) and a low sperm concentration (P < 0.05) were both found to be significant predictors for the identification of a microdeletion. Testosterone level, luteinising hormone level and testicular volume did not predict the presence of a microdeletion. None of the men with an AZF microdeletion had a sperm concentration of >0.5 million/mL. Lowering the sperm concentration threshold to this level retained the high sensitivity (100%) and increased the specificity (31%). This would produce significant cost savings when compared to the European Academy of Andrology/European Molecular Genetics Quality Network and European Association of Urology guidelines. The surgical sperm retrieval (SSR) rate after microdissection testicular sperm extraction was 33.2% in men with AZFc microdeletion. CONCLUSIONS: The prevalence of Y-chromosome microdeletions in infertile men appears to vary between populations and countries. A low sperm concentration was a predictive factor (P < 0.05) for identifying microdeletions in infertile males. A threshold for genetic testing of 0.5 million/mL would increase the specificity and lower the relative cost without adversely affecting the sensitivity. The rate of SSR was lower than that previously described in the literature.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Johnson M, Raheem A, De Luca F, et al. An analysis of the frequency of Y-chromosome microdeletions and the determination of a threshold sperm concentration for genetic testing in infertile men. BJU Int. 2018. PMID: 30113756. doi:10.1111/bju.14521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。